Effective for dates of service on or after November 6, 2022, AIM Specialty Health® (AIM) has revised their Clinical Appropriateness Guidelines for Musculoskeletal-Interventional Pain Management for Independence Blue Cross (Independence) Commercial and Medicare Advantage members. For full details, view the specific guidelines.
For more information about AIM's revised Clinical Appropriateness Guidelines for Musculoskeletal-Interventional Pain Management, please refer to the following Independence policies on our Medical and Claim Payment Policy Portal, which will be published on December 5, 2022.
- Commercial: #00.01.66g: Musculoskeletal Services (Independence)
- Medicare Advantage: #MA00.047g: Musculoskeletal Services